Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Completed OBSERVATIONAL NCT03639376

Passive Smoking and LL-37 in Children

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

This study investigates the salivary LL-37 in passive smoking-exposed and unexposed children and the association between salivary LL-37 levels and periodontal clinical parameters in these children.Unstimulated salivary samples were collected from 180 children (90 passive smoking-exposed and 90 passive smoking-unexposed)

Detailed Description

Diverse mechanisms conduce to the detrimental periodontal effects of passive smoking, including alteration of both microbial and host response factors. Antimicrobial peptides are considered to be an important intermediate step in initiating an initial immune response against the microbial side of the oral gingival epithelium and in the transition to acquired immunity. LL-37 has a wide antimicrobial activity against both cariogenic and periopathogenic bacteria and its role in maintaining oral health has recently been stated

Primary Outcomes

Measure: Antimicrobial Peptide
TimeFrame: In the first 18 months of study
Description: LL-37 (pg/mL)

Trial Information

NCT ID

NCT03639376

Status

Completed

Study Type

OBSERVATIONAL

Sponsor

Kırıkkale University

Last Updated

December 15, 2025